Document is current
Any future updates will be listed below
-
Authors
Ouedraogo, Alfred Rakissida
Traoré, Lassina
Ouattara, Abdoul Karim
Ouedraogo, Alexis Rakiswende
Zongo, Sidnooma Véronique
Savadogo, Mousso
Lallogo, Tatiana Doriane
Sombie, Herman Karim
Sorgho, Pegdwendé Abel
Ouedraogo, Teega-wendé Clarisse
Djigma, Florencia Wendkuuni
Lamien, Assita Sanou
Yonli, Albert Théophane
Lompo, Olga Mélanie
Simporé, Jacques
-
Funding
Funding for this research was provided by:
Fonds National de la Recherche et de l’Innovation pour le Devéloppement (№ AAP Rapide Covid19 mala infect_l-ll FONRID, № AAP Rapide Covid19 mala infect_l-ll FONRID)
- License Information
-
More Information
Article History
Received: 13 April 2023
Accepted: 3 October 2023
First Online: 16 October 2023
Declarations
:
: All procedures were performed in accordance with relevant guidelines and regulations. The study was approved by the National Ethics Committee for Health Research (CERS), with deliberation number 2021-02-033. Written informed consent was obtained from all participants and from the legal guardians of participants under 16 years of age. The confidentiality and anonymity of the information obtained from the different patient registries will be maintained.
: The present study was approved by the Central Regional Directorate (DRSC) and the Institutional Ethics Committee of the Biomolecular Research Center Pietro Annigoni (CERBA). Free and written informed consent was obtained from all participants in this study. The anonymity and confidentiality of the patients were respected, as stated in the IRB (Institutional Review Board) protocol.
: Not Applicable.
: The authors declare that they have no competing interests.
